diet drug candidate
Scope
Date
~
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Leadership & Management
Hyundai Mobis CEO runs for ISO president as first Korean candidate
Hyundai Mobis Co. CEO Cho Sung-hwan has registered as a candidate for the next presidential election of the International Organization for Standar...
Jun 21, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Elec. proposes global research for 6G frequencies
Samsung Electronics Co., South Korea’s tech behemoth, has put forward global research on 6G service frequencies as it aims to take the lead in...
May 09, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Corporate strategy
SK Chemicals to invest $1.6 bn in green, biopharmaceutical sectors
South Korea’s SK Chemicals plans to invest more than 2 trillion won ($1.6 billion) in eco-friendly material and biopharmaceutical businesses.T...
Mar 28, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Upcoming IPOs
Korea’s Voronoi in talks with global firms on drug designs
South Korea’s biotechnology startup Voronoi Inc. is in talks with global biomedical companies on drug designs as it aims to expand the busines...
Mar 04, 2022 (Gmt+09:00)
-
Korean biotech startup signs license deal with US firm
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Feb 17, 2022 (Gmt+09:00)
-
IPOs
Viva Republica poised to become Korea’s fourth decacorn
Viva Republica Inc., the operator of fintech platform Toss, is revving up for a pre-IPO. When finalized, the company will become South Korea’s...
Feb 02, 2022 (Gmt+09:00)
-
Digital assets
Presidential candidates vow to legislate digital assets
Ahead of the 20th presidential election slated for March 9, candidates from both parties have vowed to legislate and systemize digital assets if ele...
Jan 20, 2022 (Gmt+09:00)
-
Pharmeceuticals
Kolon resumes Invossa phase 3 clinical trials in US
Kolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28 it has resumed admi...
Dec 28, 2021 (Gmt+09:00)
-
Pharmaceuticals
HK inno.N’s K-CAB a blockbuster drug with $843 million exports
South Korea’s HK inno.N Corp. has signed a 640 billion won ($540 million) contract to license out its technology for K-CAB, a gastroesophageal...
Dec 24, 2021 (Gmt+09:00)
-
Biotech
Korea’s MedPacto, Merck plan phase 3 trials of colorectal cancer drug
MedPacto Inc., a South Korean biotechnology company that develops therapeutics for cancer and autoimmune diseases, has agreed with global drugmaker ...
Dec 15, 2021 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
Pre-IPOs
GIC, EQT, MBK compete for ADT Caps' $300 mn shares
Singapore's sovereign wealth fund GIC, Sweden-based EQT Partners and South Korea-based MBK Partners are among the four shortlisted bidders for share...
Oct 19, 2021 (Gmt+09:00)
-
Korean chipmakers
Taylor city in Texas likely to host Samsung’s new US chip plant
The global semiconductor industry is keeping a close eye on whether Taylor, a city located in Williamson County of Texas and the most probable site ...
Sep 23, 2021 (Gmt+09:00)
-
Biosimilars
Samsung Bioepis gets FDA approval for Lucentis biosimilar Byooviz
Samsung Bioepis Co., a leading South Korean biopharmaceutical company, has received approval from the US Food and Drug Administration for its Byoovi...
Sep 23, 2021 (Gmt+09:00)
-
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
Pharmaceuticals
Medytox’s US business outlook dim as contract with AbbVie ends
South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...
Sep 09, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Strategic buyers line up for IMM-led $1.3 bn Hanssem deal
LX Hausys Ltd., South Korea's leading building materials maker, on Monday announced a plan to join Seoul-based IMM Private Equity in acquiring a con...
Sep 06, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
Interpark draws cool response from Korean online giants
South Korea’s online retail platform Interpark Corp. has failed to drum up interest from the country's largest online platforms, including Nav...
Aug 31, 2021 (Gmt+09:00)
-
Capital raising
SK E&S' $2 bn preferred share deal shortlisted to four candidates
SK E&S Co., the largest city gas supplier in South Korea, has shortlisted four candidates among seven preliminary bidders to invest in 2 trillio...
Aug 13, 2021 (Gmt+09:00)
-
E-commerce
Diet boom drives Foodnamoo to 52-week high
South Korea-based Foodnamoo Inc., the operator of diet product platform Rankingdak.com, has hit a new 52-week high as its share price closed at the ...
Aug 11, 2021 (Gmt+09:00)
-
Pharmaceuticals
Daewoong Pharmaceutical aims to top $4 bn in sales by 2027
South Korea-based Daewoong Pharmaceutical Co. is hoping to achieve 5 trillion won ($4.4 billion) in sales by 2027, meaning that the company aims to ...
Aug 04, 2021 (Gmt+09:00)
language -
Entertainment
CJ joins race for over $200 mn stake in SM Entertainment
South Korea's entertainment- and food-focused CJ Group has emerged as a darkhorse to buy a controlling stake worth about 300 billion won ($260 milli...
Aug 03, 2021 (Gmt+09:00)
language -
Biotech
LegoChem’s biotech platform drives 28% share price spike over last month
The rise of the platform economy is a global phenomenon. The spread of the coronavirus pandemic has accelerated the use of contactless technology an...
Jul 07, 2021 (Gmt+09:00)
language
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand